Insights & Resources | Pfizer CentreOne

Placing Drug Strategies on a Solid Foundation for Success

Our whitepaper explores current market dynamics and the latest drug development trends driving these strategic outsourcing decisions.

Migrating A Drug Product Presentation From Vial To Prefilled Syringe - On Drug Delivery

This article explores some of the leading engineering activities that are necessary for successful PFS transfers and the benefits they offer.

Understanding the Challenges of Highly Potent Actives - International Pharmaceutical Industry

From managing health and safety risks to effective potency classifications, there are many challenges pharmaceutical companies face when using highly potent active pharmaceutical ingredients (HPAPIs) for the first time. This article explores these challenges in-depth and how they can be overcome.

Pfizer CenterOne’s Enviero® receives first EU authorization as part of ESTIMA® (progesterone) product approval.

Pfizer CentreOne’s green-chemistry progesterone API, Enviero®, has been approved for use in the EU for the first time in a drug product manufactured by French pharmaceutical company, Effik.

Highly Potent Oral Solids: Top Considerations

Understanding product classification and the heightened complexity of HPAPI drug substance transfer and manufacturing is critical. Developers are increasingly working with CDMOs to commercialize their HPAPIs. Kieran Coffey, Technical Services Lead at Pfizer CentreOne, discusses these key considerations

Experience the Art of Science - Debbie Lemons's story

In this instalment of our ‘Experience the Art of Science’ blog series, we meet Debbie Lemons, Senior Regulatory Compliance External Lead Auditor at our Rocky Mount facility.

Building More Resilient API Supply Chains

Safe, secure and reliable supply lines for key medicines is one of pharma's top priorities. However, as recent reports about shortages of active pharmaceutical ingredients (APIs) impacting on the supply of key medicines show, there are lessons to be learned to ensure optimum supply chain security.

How to Secure a Sustainable Supply of Raw Materials

There are a few steps pharmaceutical companies can take to minimize insecurity in their supply chain even in a rapidly changing market, find out what these are in this article.

Your Questions Answered - Highly Potent Oral Solids Q&A

Pfizer CentreOne’s OSD experts answer your questions following our recent webinar on the challenges and considerations for a highly potent oral solids project.

The path to a secure supply chain – 10 questions to ask

In this e-Book, Jim Carr, Operations Lead for APIs & Intermediates at Pfizer CentreOne discusses the 10 key questions to ask when diversifying your API supply chain and how our team of experts can work with you to achieve this.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne, Medicine Maker

Andrew Moore, GM of Pfizer CentreOne spoke to the Medicine Maker to discuss his leadership journey, his goals for the business and his leadership advice.

Webinar | Highly Potent Oral Solids: Challenges and Considerations

In this webinar Pfizer CentreOne’s oral solids (OSD) experts discuss key consideration highly potent oral solids (HPOSD), focusing on three key challenges faced during development and manufacture.